Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2016

01-02-2016 | Research Article

Chronotherapy in practice: the perspective of the community pharmacist

Authors: Gagandeep Kaur, Yuh-Lin Gan, Craig L Phillips, Keith Wong, Bandana Saini

Published in: International Journal of Clinical Pharmacy | Issue 1/2016

Login to get access

Abstract

Background Optimising the time of drug administration in alignment with circadian rhythms to enhance the clinical effect or minimise/avoid adverse effects is referred to as chronotherapy. Pharmacists have a key role in providing medicine related information, including counselling about the optimal time for medication administration. Where applicable, the principles of chronotherapy should underlie this aspect of medication counselling. Despite significant developments in the science of chronotherapy for specific pharmacological treatments, the perspective of pharmacists about their understanding and application of these principles in practice has not been explored. Objective To explore community pharmacist’s viewpoints about and experience with the application of chronotherapy principles in practice. Setting Community pharmacies within metropolitan Sydney in New South Wales, Australia. Methods Semi-structured, face to face interviews with a convenience sample of community pharmacists were conducted. All interviews were audio-recorded, transcribed verbatim and thematically analyzed using a ‘grounded theory’ approach, given the novelty of this area. Main outcome measure Community pharmacists’ awareness, current practice and future practice support requirements about the principles of chronotherapy. Results Twenty-five semi-structured interviews were conducted. Most participants reported encountering cases where clinical decision making about suggesting appropriate times of drug administration to patients was needed. Their approach was mainly pragmatic rather than based on theoretical principles of circadian variation in drug disposition or on current or emerging evidence; thus there was an evidence practice chasm in some cases. However, most participants believed they have an important role to play in counselling patients about optimal administration times and were willing to enact such roles or acquire skills/competence in this area. Conclusion Community pharmacists contribute to the safe and effective use of medications in providing the patients with information on optimal timing of drug administration during counselling. Further education, practical training and access to information may help pharmacists in translating principles of chronotherapy into the practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ortiz M, Cecere R, Gallagher R. Impact of the Mirixa Program on patient compliance to therapy. Aust Pharm. 2011;30(3):244. Ortiz M, Cecere R, Gallagher R. Impact of the Mirixa Program on patient compliance to therapy. Aust Pharm. 2011;30(3):244.
2.
go back to reference Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):825–7.CrossRefPubMed Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):825–7.CrossRefPubMed
3.
go back to reference Sajan J, Cinu T, Chacko A, Litty J, Jaseeda T. Chronotherapeutics and chronotherapeutic drug delivery systems. Trop J Pharm Res. 2009;8(5):467–75.CrossRef Sajan J, Cinu T, Chacko A, Litty J, Jaseeda T. Chronotherapeutics and chronotherapeutic drug delivery systems. Trop J Pharm Res. 2009;8(5):467–75.CrossRef
4.
go back to reference Smolensky MH, Siegel RA, Haus E, Hermida RC, Portaluppi F. Biological rhythms, drug delivery, and chronotherapeutics. In: Siepmann J, Siegel RA, Rathbone MJ, editors. Fundamentals and applications of controlled release drug delivery. Advances in delivery science and technology. New York: Springer; 2012. p. 359–443.CrossRef Smolensky MH, Siegel RA, Haus E, Hermida RC, Portaluppi F. Biological rhythms, drug delivery, and chronotherapeutics. In: Siepmann J, Siegel RA, Rathbone MJ, editors. Fundamentals and applications of controlled release drug delivery. Advances in delivery science and technology. New York: Springer; 2012. p. 359–443.CrossRef
5.
go back to reference Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int. 2002;19(1):237–51 (Epub 2002/04/19).CrossRefPubMed Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int. 2002;19(1):237–51 (Epub 2002/04/19).CrossRefPubMed
6.
go back to reference Hermida RC, Calvo C, Ayala DE, Covelo M, Rodriguez M, Lopez JE. Administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in patients with essential hypertension. Am J Hypertens. 2005;18(S4):63A. Hermida RC, Calvo C, Ayala DE, Covelo M, Rodriguez M, Lopez JE. Administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in patients with essential hypertension. Am J Hypertens. 2005;18(S4):63A.
7.
go back to reference Ohdo S. Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety. Drug Saf. 2003;26(14):999–1010 (Epub 2003/10/30).CrossRefPubMed Ohdo S. Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety. Drug Saf. 2003;26(14):999–1010 (Epub 2003/10/30).CrossRefPubMed
8.
go back to reference Ji M, Li X-D, Zhang H, Ning Z-H, Zhang X, Zhao W-Q, et al. Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China. Tumor Biol. 2014;35(12):12285–92.CrossRef Ji M, Li X-D, Zhang H, Ning Z-H, Zhang X, Zhao W-Q, et al. Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China. Tumor Biol. 2014;35(12):12285–92.CrossRef
9.
go back to reference Youan B-BC. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Control Release. 2004;98(3):337–53.CrossRefPubMed Youan B-BC. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Control Release. 2004;98(3):337–53.CrossRefPubMed
10.
go back to reference Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis. 2013;72(2):204–10.CrossRefPubMed Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis. 2013;72(2):204–10.CrossRefPubMed
11.
go back to reference Kaur G, Phillips C, Wong K, Saini B. Timing is important in medication administration: a timely review of chronotherapy research. Int J Clin Pharm. 2013;35(3):344–58.CrossRefPubMed Kaur G, Phillips C, Wong K, Saini B. Timing is important in medication administration: a timely review of chronotherapy research. Int J Clin Pharm. 2013;35(3):344–58.CrossRefPubMed
12.
go back to reference Strohl KP, Veasey S, Harding S, Skatrud J, Berger HA, Papp KK, et al. Competency-based goals for sleep and chronobiology in undergraduate medical education. Sleep. 2003;26(3):333–6 (Epub 2003/05/17).PubMed Strohl KP, Veasey S, Harding S, Skatrud J, Berger HA, Papp KK, et al. Competency-based goals for sleep and chronobiology in undergraduate medical education. Sleep. 2003;26(3):333–6 (Epub 2003/05/17).PubMed
13.
go back to reference Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes. Sleep Med Rev. 2015;21:3–11.CrossRefPubMed Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes. Sleep Med Rev. 2015;21:3–11.CrossRefPubMed
14.
go back to reference Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev. 2015;21:12–22.CrossRefPubMed Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev. 2015;21:12–22.CrossRefPubMed
15.
go back to reference Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010;15(4):173–80.CrossRefPubMed Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010;15(4):173–80.CrossRefPubMed
16.
go back to reference Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. Bedtime hypertension chronotherapy: concepts and patient outcomes. Curr Pharm Des. 2015;21(6):773–90.CrossRefPubMed Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. Bedtime hypertension chronotherapy: concepts and patient outcomes. Curr Pharm Des. 2015;21(6):773–90.CrossRefPubMed
17.
go back to reference Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens. 2001;14(9):S280–90.CrossRef Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens. 2001;14(9):S280–90.CrossRef
19.
go back to reference Yi-F Guo. Stein PK. Circadian rhythm in the cardiovascular system: chronocardiology. Am Heart J. 2003;145(5):779–86.CrossRef Yi-F Guo. Stein PK. Circadian rhythm in the cardiovascular system: chronocardiology. Am Heart J. 2003;145(5):779–86.CrossRef
20.
go back to reference Ernst ME. Ambulatory blood pressure monitoring: recent evidence and clinical pharmacy applications. Pharmacotheraphy. 2013;33(1):69–83.CrossRef Ernst ME. Ambulatory blood pressure monitoring: recent evidence and clinical pharmacy applications. Pharmacotheraphy. 2013;33(1):69–83.CrossRef
21.
go back to reference Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 2007;59(9):923–39.CrossRefPubMed Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 2007;59(9):923–39.CrossRefPubMed
22.
go back to reference Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58(11):1165–73.CrossRefPubMed Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58(11):1165–73.CrossRefPubMed
23.
go back to reference Hermida RC, Ayala DE, Fernández JR, Mojón A. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013;30(1–2):68–86.CrossRefPubMed Hermida RC, Ayala DE, Fernández JR, Mojón A. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013;30(1–2):68–86.CrossRefPubMed
24.
go back to reference Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, et al. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int. 2013;30(1–2):176–91.CrossRefPubMed Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, et al. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int. 2013;30(1–2):176–91.CrossRefPubMed
25.
go back to reference Hermida RC, Ayala DE, Mojón A, Fernández JR. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 2013;30(1–2):315–27.CrossRefPubMed Hermida RC, Ayala DE, Mojón A, Fernández JR. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 2013;30(1–2):315–27.CrossRefPubMed
26.
go back to reference Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30(1–2):145–58.CrossRefPubMed Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30(1–2):145–58.CrossRefPubMed
27.
go back to reference Guidelines for the clinical use of. 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest version. Circ J. 2012;76(2):508–19 (Epub 2012/01/11).CrossRef Guidelines for the clinical use of. 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest version. Circ J. 2012;76(2):508–19 (Epub 2012/01/11).CrossRef
28.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef
29.
go back to reference Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. Treatment of hypertension with chronotherapy: is it time of drug administration? Ann Pharmacother. 2015;49(3):323–34 (Epub 2014/12/18).CrossRefPubMed Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. Treatment of hypertension with chronotherapy: is it time of drug administration? Ann Pharmacother. 2015;49(3):323–34 (Epub 2014/12/18).CrossRefPubMed
30.
go back to reference Smolensky MH. Knowledge and attitudes of American physicians and public about medical chronobiology and chronotherapeutics. Findings of two 1996 Gallup surveys. Chronobiol Int. 1998;15(4):377–94 (Epub 1998/08/26).CrossRefPubMed Smolensky MH. Knowledge and attitudes of American physicians and public about medical chronobiology and chronotherapeutics. Findings of two 1996 Gallup surveys. Chronobiol Int. 1998;15(4):377–94 (Epub 1998/08/26).CrossRefPubMed
32.
go back to reference Corbin J, Strauss A. Grounded theory methodology. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Beverly Hills: Sage; 1994. p. 273–85. Corbin J, Strauss A. Grounded theory methodology. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Beverly Hills: Sage; 1994. p. 273–85.
35.
go back to reference Zhu LL, Zhou Q, Yan XF, Zeng S. Optimal time to take once-daily oral medications in clinical practice. Int J Clin Pract. 2008;62(10):1560–71.CrossRefPubMed Zhu LL, Zhou Q, Yan XF, Zeng S. Optimal time to take once-daily oral medications in clinical practice. Int J Clin Pract. 2008;62(10):1560–71.CrossRefPubMed
36.
go back to reference Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162–71.CrossRefPubMed Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162–71.CrossRefPubMed
37.
go back to reference Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2015;162(3):192–204.CrossRefPubMed Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2015;162(3):192–204.CrossRefPubMed
38.
go back to reference Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, et al. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 2013;30(1–2):99–115.CrossRefPubMed Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, et al. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 2013;30(1–2):99–115.CrossRefPubMed
39.
go back to reference Hermida RC, Ayala DE, Mojón A, Fernández JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol Int. 2013;30(1–2):87–98.CrossRefPubMed Hermida RC, Ayala DE, Mojón A, Fernández JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol Int. 2013;30(1–2):87–98.CrossRefPubMed
40.
go back to reference Crespo JJ, Moya A, Otero A, Dominguez-Sardiña M, Pousa L, Callejas PA, et al. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level: the Hygia Project. J Am Soc Hypertens. 2014;8(4):e49.CrossRef Crespo JJ, Moya A, Otero A, Dominguez-Sardiña M, Pousa L, Callejas PA, et al. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level: the Hygia Project. J Am Soc Hypertens. 2014;8(4):e49.CrossRef
41.
go back to reference Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40–6.CrossRefPubMed Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40–6.CrossRefPubMed
42.
go back to reference Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 1993;54(2):177–86.CrossRefPubMed Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 1993;54(2):177–86.CrossRefPubMed
43.
go back to reference Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, et al. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol. 1993;31(6):295–300.PubMed Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, et al. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol. 1993;31(6):295–300.PubMed
44.
go back to reference Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15(2):205–11.CrossRefPubMed Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15(2):205–11.CrossRefPubMed
45.
go back to reference De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 2013;24(8):698–706.CrossRefPubMed De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 2013;24(8):698–706.CrossRefPubMed
46.
go back to reference Lincoln YS, Guba EG. Naturalist inquiry. Beverly Hills: Sage; 1985. Lincoln YS, Guba EG. Naturalist inquiry. Beverly Hills: Sage; 1985.
47.
go back to reference Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed
49.
go back to reference Lawrence J, Tar U. The use of grounded theory technique as a practical tool for qualitative data collection and analysis. Electron J Bus Res Methods. 2013;11(1):29–40. Lawrence J, Tar U. The use of grounded theory technique as a practical tool for qualitative data collection and analysis. Electron J Bus Res Methods. 2013;11(1):29–40.
50.
go back to reference Creswell JW. Qualitative inquiry and research design: choosing among five approaches. 3rd ed. London: Sage; 2013. Creswell JW. Qualitative inquiry and research design: choosing among five approaches. 3rd ed. London: Sage; 2013.
51.
go back to reference Cho JY, Lee E-H. Reducing confusion about grounded theory and qualitative content analysis: similarities and differences. Qual Rep. 2014;19(32):1–20. Cho JY, Lee E-H. Reducing confusion about grounded theory and qualitative content analysis: similarities and differences. Qual Rep. 2014;19(32):1–20.
52.
go back to reference Alsaikhan MAA-EF, Alsubaie M, Aldosari SA, Alhamaad A. Antihypertensive medications and chronopharmacology: role of Saudi pharmacists in patient education. Int J Dev Res. 2015;5(3):3831–5. Alsaikhan MAA-EF, Alsubaie M, Aldosari SA, Alhamaad A. Antihypertensive medications and chronopharmacology: role of Saudi pharmacists in patient education. Int J Dev Res. 2015;5(3):3831–5.
53.
go back to reference Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59(9–10):852–82 (Epub 2007/09/29).CrossRefPubMed Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59(9–10):852–82 (Epub 2007/09/29).CrossRefPubMed
54.
go back to reference Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95(5 Pt 2):1084–96 (Epub 1995/05/01).CrossRefPubMed Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95(5 Pt 2):1084–96 (Epub 1995/05/01).CrossRefPubMed
55.
go back to reference Mormont MC, Lévi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241–7.CrossRefPubMed Mormont MC, Lévi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241–7.CrossRefPubMed
56.
go back to reference Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J. 1990;120(3):726–33 (Epub 1990/09/01).CrossRefPubMed Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J. 1990;120(3):726–33 (Epub 1990/09/01).CrossRefPubMed
57.
go back to reference Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 2002;61(12):1075–80 (Epub 2002/11/14).CrossRefPubMedPubMedCentral Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 2002;61(12):1075–80 (Epub 2002/11/14).CrossRefPubMedPubMedCentral
58.
59.
go back to reference Lemmer B, Scheidel B, Behne S. Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs. Propranolol, organic nitrates, nifedipine. Ann N Y Acad Sci. 1991;618:166–81 (Epub 1991/01/01).CrossRefPubMed Lemmer B, Scheidel B, Behne S. Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs. Propranolol, organic nitrates, nifedipine. Ann N Y Acad Sci. 1991;618:166–81 (Epub 1991/01/01).CrossRefPubMed
60.
go back to reference Smolensky MH, Hermida RC, Haus E, Portaluppi F, Reinberg A. Biological rhythms, medication safety, and women’s health. J Womens Health. 2005;14(1):38–46.CrossRef Smolensky MH, Hermida RC, Haus E, Portaluppi F, Reinberg A. Biological rhythms, medication safety, and women’s health. J Womens Health. 2005;14(1):38–46.CrossRef
61.
go back to reference Erkekoglu P, Baydar T. Chronopharmacodynamics of drugs in toxicological aspects: a short review for clinical pharmacists and pharmacy practitioners. J Res Pharm Pract. 2012;1(2):41.CrossRefPubMedPubMedCentral Erkekoglu P, Baydar T. Chronopharmacodynamics of drugs in toxicological aspects: a short review for clinical pharmacists and pharmacy practitioners. J Res Pharm Pract. 2012;1(2):41.CrossRefPubMedPubMedCentral
62.
go back to reference Touitou Y, Haus E, editors. Biologic rhythms in clinical and laboratory medicine. Berlin: Springer; 1992. Touitou Y, Haus E, editors. Biologic rhythms in clinical and laboratory medicine. Berlin: Springer; 1992.
63.
go back to reference Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 1996;9(4 Pt 3):11s–21s (Epub 1996/04/01).CrossRefPubMed Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 1996;9(4 Pt 3):11s–21s (Epub 1996/04/01).CrossRefPubMed
64.
go back to reference Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):828–51.CrossRefPubMed Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):828–51.CrossRefPubMed
65.
go back to reference Ohdo S. Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption. Adv Drug Deliv Rev. 2010;62(9–10):859–75.CrossRefPubMed Ohdo S. Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption. Adv Drug Deliv Rev. 2010;62(9–10):859–75.CrossRefPubMed
66.
go back to reference Lee KA, Landis C, Chasens ER, Dowling G, Merritt S, Parker KP, et al. Sleep and chronobiology: recommendations for nursing education. Nurs Outlook. 2004;52(3):126–33.CrossRefPubMed Lee KA, Landis C, Chasens ER, Dowling G, Merritt S, Parker KP, et al. Sleep and chronobiology: recommendations for nursing education. Nurs Outlook. 2004;52(3):126–33.CrossRefPubMed
67.
go back to reference Strohl KP, Haponik EE, Sateia MJ, Veasy S, Chervin RD, Zee P, et al. The need for a knowledge system in sleep and chronobiology. Acad Med. 2000;75(8):819–21.CrossRefPubMed Strohl KP, Haponik EE, Sateia MJ, Veasy S, Chervin RD, Zee P, et al. The need for a knowledge system in sleep and chronobiology. Acad Med. 2000;75(8):819–21.CrossRefPubMed
68.
go back to reference Costa de Sousa I, de Lima Pereira, David J, Noblat LdACB. A drug information center module to train pharmacy students in evidence-based practice. Am J Pharm Educ. 2013;77(4):80.CrossRefPubMedCentral Costa de Sousa I, de Lima Pereira, David J, Noblat LdACB. A drug information center module to train pharmacy students in evidence-based practice. Am J Pharm Educ. 2013;77(4):80.CrossRefPubMedCentral
69.
go back to reference Puspitasari HP, Aslani P, Krass I. Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PLoS ONE. 2014;9(11):e113337.CrossRefPubMedPubMedCentral Puspitasari HP, Aslani P, Krass I. Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PLoS ONE. 2014;9(11):e113337.CrossRefPubMedPubMedCentral
70.
go back to reference Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens. 2012;30(2):253–66.CrossRefPubMed Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens. 2012;30(2):253–66.CrossRefPubMed
71.
go back to reference Culverhouse S, Wohlmuth H. Factors affecting pharmacists’ recommendation of complementary medicines—a qualitative pilot study of Australian pharmacists. BMC Complement Altern Med. 2012;12(1):183.CrossRefPubMedPubMedCentral Culverhouse S, Wohlmuth H. Factors affecting pharmacists’ recommendation of complementary medicines—a qualitative pilot study of Australian pharmacists. BMC Complement Altern Med. 2012;12(1):183.CrossRefPubMedPubMedCentral
72.
go back to reference Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Social Adm Pharm. 2009;5(3):197–210.CrossRefPubMed Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Social Adm Pharm. 2009;5(3):197–210.CrossRefPubMed
73.
go back to reference Hanes CA, Wong KK, Saini B. Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience. Int J Clin Pharm. 2014;36(2):460–8.CrossRefPubMed Hanes CA, Wong KK, Saini B. Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience. Int J Clin Pharm. 2014;36(2):460–8.CrossRefPubMed
Metadata
Title
Chronotherapy in practice: the perspective of the community pharmacist
Authors
Gagandeep Kaur
Yuh-Lin Gan
Craig L Phillips
Keith Wong
Bandana Saini
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0228-7

Other articles of this Issue 1/2016

International Journal of Clinical Pharmacy 1/2016 Go to the issue